Form D · Biotechnology
Lotus Bio-Technology Development Corp.
Costa Mesa, CA · CIK 0001520592
Offering snapshot reported Dec 23, 2022 · SEC filing
- Reported sold
- $50K Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Dec 14, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 23, 2022 | Initial | $50,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-468619
Not to exceed $500,000.
Source: Form D, filed Dec 23, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Hoyt Christopher | Director, Executive |
| William Mc Donald | Director |
| Michael Jay Solomon | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1927 Harbor Blvd. Suite 710
Costa Mesa, CA, 92627
Costa Mesa, CA, 92627